Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance

5Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Very late stent thrombosis (VLST) after implantation of drug-eluting stent is rare, but very fatal complication after percutaneous coronary intervention. We report a case of VLST of a sirolimus-eluting Cypher™ stent (Cordis, Johnson and Johnson) presenting as acute ST elevation myocardial infarction at 26 months after deployment with continued combined dual antiplatelet medication of aspirin and clopidogrel. The patient did not show anti-platelet resistance. Copyright © The Korean Academy of Medical Sciences.

Cite

CITATION STYLE

APA

Sang, Y. L., Ki, S. K., Seung, J. J., & Myung, H. J. (2008). Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance. Journal of Korean Medical Science, 23(3), 556–559. https://doi.org/10.3346/jkms.2008.23.3.556

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free